ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,095, issued on Dec. 2, was assigned to ACTIVE BIOTECH AB (Lund, Sweden).
"Plurality of tasquinimod particles and use thereof" was invented by Hans Wannman (Angelholm, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "A plurality of particles of tasquinimod in free base form or as a pharmaceutically acceptable salt, said particles having a D(v, 0.9) of at most 30 pm and a D(v, 0.5) of at most 15 micro metre. A pharmaceutical composition comprising said particles and preferably one or more pharmaceutically acceptable excipients. A pharmaceutical dosage unit. The particles, composition and dosage unit are useful in the treatment of cancer."
The pat...